← Back to Patent Explorer
US4526909A Expired / Lapsed US ⏱️ 0.0 years remaining

Polymethylmethacrylate delivery system for bone morphogenetic protein

Assignee: University of California
•
Filing: 1984-01-09
•
Granted: 1985-07-02
•
Expires: 2004-01-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A delivery system for delivering bone morphogenetic protein to induce formation of new bone in viable tissue. The delivery composition comprises substantially pure bone morphogenetic protein and polymethylmethacrylate and it is prepared by admixing the bone morphogenetic protein and polymethylmethacrylate. The composition is implanted in viable tissue where the bone morphogenetic protein is slowly released and induces formation of new bone.

Inventors

  • 👤 Marshall R. Urist

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 00:35
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/14; A61L27/26; A61L24/00; A61L24/001; A61L24/0015; A61L24/04; A61L24/043; A61L27/50; A61L27/54; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/406; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/84; Y10S623/00; Y10S623/915; Y10S623/919

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 13 words
A composition comprising substantially pure bone morphogenetic protein and a polymeric acrylic ester.
Claim 2
Dependent Claim 13 words
A composition comprising substantially pure bone morphogenetic protein and a polymeric acrylic ester.
Claim 3
Dependent Claim 25 words
A delivery composition for delivering bone morphogenetic protein to induce formation of new bone in viable tissue comprising substantially pure bone morphogenetic protein and polymethylmethacrylate.
Claim 4
Dependent Claim 25 words
A delivery composition for delivering bone morphogenetic protein to induce formation of new bone in viable tissue comprising substantially pure bone morphogenetic protein and polymethylmethacrylate.
Claim 5
Dependent Claim 45 words
The delivery composition for delivering bone morphogenetic protein to induce formation of new bone in viable tissue, comprising bone morphogenetic protein and polymethylmethacrylate wherein the weight ratio of bone morphogenetic protein to polymethylmethacrylate is at least 0.05 parts bone morphogenetic protein to 16 parts polymethylmethacrylate.
Claim 6
Dependent Claim 45 words
The delivery composition for delivering bone morphogenetic protein to induce formation of new bone in viable tissue, comprising bone morphogenetic protein and polymethylmethacrylate wherein the weight ratio of bone morphogenetic protein to polymethylmethacrylate is at least 0.05 parts bone morphogenetic protein to 16 parts polymethylmethacrylate.
Claim 7
Dependent Claim 26 words
The delivery composition of claim 3 wherein said weight ratio is in the range of up to 2.0 parts bone morphogenetic protein to 16 parts polymethylmethacrylate.
Claim 8
Dependent Claim 13 words
The delivery composition of claim 3 including in said composition a radioopacifying agent.
Claim 9
Dependent Claim 12 words
The delivery composition of claim 3 including in said composition an antibiotic.
Claim 10
Independent Claim 47 words
The method of preparing a delivery composition for deliverying bone morphogenetic protein to induce formation of new bone in viable tissue comprising the step of admixing bone morphogenetic protein and polymethylmethacrylate in a weight ratio of at least 0.05 parts bone morphogenetic protein to 16 parts polymethylmethacrylate.
Claim 11
Independent Claim 47 words
The method of preparing a delivery composition for deliverying bone morphogenetic protein to induce formation of new bone in viable tissue comprising the step of admixing bone morphogenetic protein and polymethylmethacrylate in a weight ratio of at least 0.05 parts bone morphogenetic protein to 16 parts polymethylmethacrylate.
Claim 12
Dependent Claim 20 words
The method of claim 7 including the step of admixing liquid methylmethacrylate monomer with the bone morphogenetic protein polymethylmethacrylate admixture.
Claim 13
Dependent Claim 24 words
The method of claim 8 wherein the ratio of polymethylmethacrylate to methylmethacrylate is about 2 to 1, weight in grams to volume in milliliters.
Claim 14
Independent Claim 41 words
The method of inducing formation of new bone in viable tissue comprising implanting in viable tissue a delivery composition comprising bone morphogenetic protein and polymethylmethacrylate wherein the weight ratio is at least 0.05 parts bone morphogenetic protein to 16 parts polymethylmethacrylate.
Claim 15
Independent Claim 41 words
The method of inducing formation of new bone in viable tissue comprising implanting in viable tissue a delivery composition comprising bone morphogenetic protein and polymethylmethacrylate wherein the weight ratio is at least 0.05 parts bone morphogenetic protein to 16 parts polymethylmethacrylate.

References Cited (Backward Citations)

US4294753A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-07-01 1988-12-31 1989-07-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-07-01 1992-12-31 1993-07-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-07-01 1996-12-31 1997-07-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag